Latest Close
$75.40
Stock Hub
ANIP
ANI Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. Use the sections below to move between chart, technical analysis, fundamentals, and news.
1y Change
$13.74 (+22.28%)
Market Cap
$1.71B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Recommendation
buy
52W Range
$59.61 to $99.50
Target Mean Price
$109.88
Beta
0.46
Trailing P/E
19.28
Forward P/E
7.11
Price / Book
2.86
Company Overview
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.